Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$393,413
+$90,809 QoQ
Shares Held
328
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#3,947
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CacheTech Inc. holds $5,715,262 across 7 Drug Manufacturers - General names. LLY ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
12,211 | $1,542,737 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
26,692 | $1,537,993 | |
| 3 | ABBV |
AbbVie Inc.
|
4,610 | $1,160,060 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,732 | $479,562 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
328 | $393,413 | |
| 6 | JNJ |
Johnson & Johnson
|
1,260 | $320,002 | |
| 7 | PFE |
Pfizer Inc
|
11,690 | $281,495 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,413 | 328 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $302,604 | 329 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $353,569 | 329 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $255,605 | 335 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $261,142 | 335 | Shares | Sole | 2025-09-25 | |
| 2025-03-31 | $276,679 | 335 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $270,200 | 350 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $402,216 | 454 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $370,300 | 409 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||